Works matching IS 00071048 AND DT 2018 AND VI 182 AND IP 3
Results: 24
Combination targeted therapy in chronic lymphocytic leukaemia – can pre‐clinical studies translate to the clinic?
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 315, doi. 10.1111/bjh.15279
- By:
- Publication type:
- Article
Guideline for the treatment of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 344, doi. 10.1111/bjh.15460
- By:
- Publication type:
- Article
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT‐737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 360, doi. 10.1111/bjh.15282
- By:
- Publication type:
- Article
Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 404, doi. 10.1111/bjh.15411
- By:
- Publication type:
- Article
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 418, doi. 10.1111/bjh.15407
- By:
- Publication type:
- Article
Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 412, doi. 10.1111/bjh.15406
- By:
- Publication type:
- Article
Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 423, doi. 10.1111/bjh.15404
- By:
- Publication type:
- Article
Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 384, doi. 10.1111/bjh.15410
- By:
- Publication type:
- Article
Transcriptomic rationale for synthetic lethality‐targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 373, doi. 10.1111/bjh.15408
- By:
- Publication type:
- Article
Management of post‐transplant lymphoproliferative disorders.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 330, doi. 10.1111/bjh.15263
- By:
- Publication type:
- Article
Pathogenesis, diagnosis and treatment of anaemia in immune‐mediated gastrointestinal disorders.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 319, doi. 10.1111/bjh.15254
- By:
- Publication type:
- Article
Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
The diversity of neutrophil inclusion bodies in fulminant sepsis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Issue Information.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 309, doi. 10.1111/bjh.14939
- Publication type:
- Article
Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1–2 study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 453, doi. 10.1111/bjh.14817
- By:
- Publication type:
- Article
Decrease of externalized phosphatidylserine density on red blood cell‐derived microparticles in SCA patients treated with hydroxycarbamide.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 448, doi. 10.1111/bjh.14810
- By:
- Publication type:
- Article
Effect of N‐acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 444, doi. 10.1111/bjh.14809
- By:
- Publication type:
- Article
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
- By:
- Publication type:
- Article
Factors predicting the identification of new organisms in follow‐up blood cultures drawn during episodes of neutropenic sepsis.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 451, doi. 10.1111/bjh.14814
- By:
- Publication type:
- Article
Management of pregnancy in type 3 von Willebrand disease with alloantibodies.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 429, doi. 10.1111/bjh.14793
- By:
- Publication type:
- Article
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 427, doi. 10.1111/bjh.14783
- By:
- Publication type:
- Article
Cytogenetic findings in WHO‐defined polycythaemia vera and their prognostic relevance.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 437, doi. 10.1111/bjh.14798
- By:
- Publication type:
- Article
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B‐cell precursor acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 434, doi. 10.1111/bjh.14794
- By:
- Publication type:
- Article